Plethico Pharmaceuticals - News

NSE: PLETHICO | BSE: 532739

₹7.94

₹-0.41 (-4.91%)

As on 13-Jun-2016IST

Market cap

₹27 Cr

Revenue (TTM)

₹765 Cr

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual Reports

Annual Reports

2014

Annual Reports

2012

Annual Reports

2011

Annual Reports

2009

Annual Reports

2008

Annual Reports

2007

Annual Reports

2006

Announcements

View Announcements

Recent

Important

Shareholding for the Period Ended June 30, 2016

25-Jul-2016

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

22-Jul-2016

Resignation of Director

10-May-2016

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

30-Apr-2016

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

26-Apr-2016

Shareholding for the Period Ended March 31, 2016

21-Apr-2016

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016

20-Apr-2016

28-Mar-2016

Shareholding Pattern For September 30, 2015

23-Mar-2016

Shareholding Pattern For June 30, 2015

23-Mar-2016